Navigation Links
Normal tissue not spared in new forms of breast cancer radiotherapy
Date:10/30/2007

JACKSONVILLE, Fla. − A five day course of radiotherapy to treat breast cancer may, in some cases, expose as much lung and heart tissue to potentially toxic radiation as does the standard six weeks of treatment, say researchers at Mayo Clinic Jacksonville.

That because the short treatment, known as partial breast irradiation, focus radiation to a small sector of the breast through multiple beams, these beams can pass through the breast to the heart and lungs that lie behind, researchers found. Radiating the entire breast over weeks, as is standard practice, can expose much of the heart and lungs to long periods of lower dose radiation, they say.

These findings, presented at the annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO), suggest that both methods carry risks and benefits that may be equivalent, says the studys lead investigator, Laura Vallow, M.D.

This tells us that the standard course of therapy isnt that bad in terms of its exposure to normal tissue, but also that, sometimes, partial breast irradiation may not spare as much normal tissue as we hope, Vallow says.

Oncologists are currently testing the two modes of radiotherapy − whole breast irradiation (WBI) and 3-D conformal partial breast irradiation (PBI) − in a large federally-supported clinical trial that is enrolling thousands of women across the country who have been diagnosed with early stage breast cancer and have undergone lumpectomy.

The hope is that a short course of radiotherapy will be as effective as the much longer course, and that this could lead to increased use of breast conservation over mastectomy, Vallow says. Many women may be opting for a mastectomy instead of a lumpectomy in order to avoid weeks and weeks of radiation treatment, she says. If the results of both methods are equivalent, then perhaps some of these women will choose less drastic surgery.

In two studies being presented at ASTRO, Vallow, along with Ashley Gale, M.S., Anudh Jain, M.D., and a team of physicists at Mayo Clinic Jacksonville, used radiological parameters that were prepared for patients in the clinical trial and employed computers to assess how much of normal heart and lung tissue would be exposed if either WBI or PBI were used.

We suspect there are fundamental differences in the amount of exposure to radiation a patient has using these techniques, but no one has ever looked at how much normal tissue is spared, she says. We are interested in the finer points of treatment planning, with the ultimate goal of making treatment more tolerable with less radiation exposure.

In the first study, the researchers analyzed radiation plans for 25 patients enrolled in the clinical trial and they calculated what radiation to the lung would be if WBI or PBI was used. They found that PBI exposes a slightly larger volume of the lung to low doses of radiation, but also exposes a smaller volume of lung to high doses than WBI does.

Patients are getting more exposure overall to their lungs with partial breast irradiation but less lung tissue is irradiated to higher doses compared to whole breast irradiation, Vallow says.

For 14 of the same patients who had a lumpectomy in their left breast, investigators calculated radiation to normal heart tissue. They found that PBI and WBI delivered about the same amount of radiation to the heart of patients whose tumor was located in the middle of the breast. In patients whose tumors were closer to the armpit, PBI did not affect normal heart tissue, Vallow says.

This study shows how far we have really come in the delivery of radiotherapy, she says. We are looking for nuances of tissue exposure.


'/>"/>

Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Obese children may have abnormalities of lipoproteins
2. Inflammatory bowel disease linked to genetic abnormality
3. Anti-Cancer Drug Restores Normal Cell Growth
4. Dyslexia due to cerebellum abnormality
5. Cleft lip and palate are due to abnormality in brain structure
6. Early Detection Of Facial Abnormalities in a Fetus
7. Abnormal Brain Structure One Of The Reasons For Depression in Adolescents
8. Antidepressants Could Lead To Abnormal Bleeding
9. Test for prenatal chromosomal abnormalities using cervical swab
10. People with abnormal heart rhythms must avoid fish oil
11. Normal Blood Pressure Could Add Over 5 Years To Your Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. , with its ... B. Braun Medical Inc. , a leader in infusion therapy and pain management. ... as 90 percent of hospital patients receiving a peripheral IV catheter as part of ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
(Date:4/27/2017)... ... , ... Are you investing in the safety of your friends and family? ... summer. While most of us assume this type of accident will never happen to ... are taking the time to learn how to respond effectively or prevent these accidents ...
(Date:4/26/2017)... , ... April 26, 2017 ... ... is thrilled to announce the ATA 2017 President’s Awards recipients, comprised of ... demonstrated superior healthcare delivery. , The ATA 2017 President’s Awards recognize ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may ... pelvic conditions and has helped many women become pregnant upon treating their diagnosis. ... office-based and simple outpatient evaluations. We can provide the necessary information to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... -- Viverae ® , a leader in workplace wellness ... ® Watson Campaign Automation, implementing behavioral messaging within ... personalized experience. Through digital engagement, the platform prompts members ... time. The enhanced experience drives engagement by focusing on ... are in their journey to health. ...
Breaking Medicine Technology: